×
切換帳號
FAQ
新手指南
FAQ常見問題
學術會議
影音網
登入
×
全站搜尋
搜尋
台灣泌尿科醫學會E-School
登入
FAQ
新手指南
FAQ常見問題
學術會議
影音網
到官網
Home
到官網
Home
知識庫
目錄總覽
文件總覽
最新討論
目錄 / 資料夾
學術活動與演講
年會
2026半年會
摘要
2025年會 (UAA)
摘要
2025半年會
摘要
2024年會
摘要
2024半年會
摘要
2023年會
摘要
2023半年會
摘要
2022年會
摘要
2021年會
摘要
2021半年會
摘要
2020年會
摘要
2020半年會
摘要
2019年會
摘要
2019半年會
摘要
2018年會
摘要
2018半年會
摘要
2017年會
摘要
2017半年會
摘要
2016年會
摘要
2016半年會
摘要
2015年會
摘要
新手指南與FAQ
知識庫
最新上傳
最新上傳
(
熱門
)
最新上傳
(
熱門
)
(MP2-07) Clinical Results of Overnight Catheterization in Patients with Neurogenic Bladder
2023-07-05
(MP2-06) Bladder capacity and urinary frequency in children
2023-07-05
(MP2-05) The Predictive Factors of Common Early Complications Following Transurethral Resection of the Prostate
2023-07-05
(MP2-04) Age- and gender-specific normal post void residual urine volume in healthy adolescents
2023-07-05
(MP2-03) Deep drop: a common finding in uroflowmetry of healthy children and adolescents
2023-07-05
(MP2-02) Artificial urinary sphincters in the treatment of post-prostatectomy incontinence: A summary of 22 years of experience from 4 medical institutions
2023-07-05
(MP2-01) Comparison of Thulium Laser Enucleation and Conventional transurethral resection among BPH patients: Single center study of functional outcome
2023-07-05
(MP1-10) Progression-Free Survival Following Stereotactic Body Radiotherapy for Bone Oligometastasis in Prostate Cancer and the Effect of Different Doses: A Single-Urologist, Single-Institute Experience
2023-07-05
(MP1-09) Molecular Expression Differences between Epithelioid and Sporadic Renal Angiomyolipoma: The Role of PTEN Loss and mTOR Pathway Activation
2023-07-05
(MP1-08) The long-term survival outcome of radical prostatectomy for localized prostate cancer with positive lymph node
2023-07-05
(MP1-07) The Impact of F18-Fluciclovine Positron Emission Tomography on Prostate Cancer Managements and Outcomes After Changing Managements
2023-07-05
(MP1-06) Public Chinese Prostate Cancer Professional Series-2：Updated Treatment for Clinically Localized/Regional Lymph Node Invasion Prostate Cancer (translated from NCCN Prostate Cancer Guidelines 2023 V1)
2023-07-05
(MP1-05) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
2023-07-05
(MP1-04) Public Chinese Prostate Cancer Professional Series-1：Accurate Diagnosis of Prostate Cancer (translated from NCCN Prostate Cancer Guidelines 2023 V1)
2023-07-05
(MP1-03) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for metastatic Castration-Resistant Prostate Cancer (mCRPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
2023-07-05
(MP1-02) Public Chinese Prostate Cancer Professional Series-3：Updated Treatment for metastatic Castration-Sensitive Prostate Cancer (mCSPC) (translated from NCCN Prostate Cancer Guidelines 2023 V1)
2023-07-05
(MP1-01) A real-world experience of using Apalutamide in the treatment of metastatic hormone sensitive prostate cancer
2023-07-05
TUA 2023半年會宣傳影片--【台北馬偕醫院x淡水福容飯店x台灣泌尿科醫學會】
2023-02-10
NPD63: Robotic assisted trans-abdominal pre-peritoneal inguinal hernia repair for bilateral giant inguinoscrotal hernia
2023-01-03
NDP62: Ureteral rupture after shock wave lithotripsy for ureteral urolithiasis: A Case Report
2023-01-03
NDP61: Bladder rupture during hydrodistention for interstitial cystitis/bladder pain syndrome
2023-01-03
NDP60: Acute pancreatitis complicating with scrotal abscess: A case report
2023-01-03
NDP59: Posttraumatic testicular rupture mimicking as hydrocele : A case report and literature review
2023-01-03
NDP58: Urethral trauma with repeated massive urethrorrhagia solved by transarterial embolization
2023-01-03
<
27
28
29
30
31
32
33
34
35
36
>
/ 131